THE ANALYSIS OF CONSUMPTION MARKERS OF PARKINSON'S DISEASE TREATMENT MEDICINES IN UKRAINE

Authors

DOI:

https://doi.org/10.11603/2312-0967.2020.2.11191

Keywords:

Parkinson’s disease, growth rate, antiparkinsonian medicines, consumption markers, pharmaceutical market

Abstract

The aim of the work. The purpose of the study was to determine the features and trends of medicines consumption among the population of Ukraine for the treatment of Parkinson’s disease in natural and monetary terms for year 2014–2018.

Materials and Methods. The following methods were used during the study: logical, system analysis, comparative analysis and generalization of information.

Results and Discussion. According to the results of a retrospective analysis of the consumption of medicines for 2014–2018, it was found that the volume of retail sales of medicines had a growing trend. . The analysis of the growth rates of retail sales in terms of domestic and foreign pharmaceutical production showed negative changes in the dynamics of domestic sales of natural products in physical terms. It is proved that the number of sold packages of medicines included in the National list of essential medicines in 2018 increased by 76.86 % compared to 2014. At the same time, the number of sold packages of medicines that are not listed in the National list of essential medicines decreased in 2018 at 8.12 %.

Conclusions. The results of the analysis of indicators of sales of medicines for treatment of Parkinson’s disease indicate the prevalence of foreign products over domestic in cash and natural terms. As well main problems and prospects for the development of this segment of domestic market were identified.

Author Biographies

A. A. Kotvitska, National University of Pharmacy

DS (Pharmacy), Professor, Rector

O. S. Prokopenko, National University of Pharmacy

PhD student, Department of Social Pharmacy

References

11 kvitnia – Vsesvitnii den borotby z khvoroboiu Parkinsona [Internet]. Tsentr hromadskoho zdorovia MOZ Ukrainy. [cited 2020April30]. Available from: https://phc.org.ua/news/11-kvitnya-vsesvitniy-den-borotbi-z-khvoroboyu-parkinsona

Zakon Ukrainy «Pro derzhavni harantii medychnoho obsluhovuvannia naselennia» [Internet]. Zakonodavstvo Ukrainy. [cited 2020Mar10]. Available from: https://zakon.rada.gov.ua/laws/show/2168

Natsionalnyi perelik osnovnykh likarskykh zasobiv [Internet]. Ministerstvo okhorony zdorovia. 2017 [cited 2020Mar15]. Available from: moz.gov.ua/uploads/0/290-nacionalnij_perelik_osnovnih_likarskih_zasobiv.pdf

Kotvitska AA, Lobova IO. Analiz spozhyvannia neiroprotektornykh likarskykh zasobiv dlia likuvannia ishemichnoho insultu v ukraini. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. 2013;5(31):49–58.

Doslidzhennia farmatsevtychnoho rynku Ukrainy analitychnoi kompanii «Farmstandart» kompanii «Morion». [cited 2020Feb10]. Available from: http://www.pharmstandart.com.ua/login

Kotvitska AA, Prokopenko OS. Monitoring of indicators of physical and socio-economic availability of medicines used for Parkinson’s disease treatment. Upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï. 2019;0(3 (59):55–63. DOI: https://doi.org/10.24959/uekj.19.15

WHOCC ATC/DDD Index 2020 [Internet]. WHOCC. [cited 2020Feb15]. Available from: https://www.whocc.no/atc_ddd_index/

Levytska OR, Hromovyk BP. Porivnialnyi analiz spozhyvannia likarskykh zasobiv patsiientamy z hostrymy porushenniamy mozkovoho krovoobihu u zakladakh okhorony zdorovia statsionarnoho typu. Klinichna farmatsiia, farmakoterapiia ta medychna standartyzatsiia. 2015;(3-4):70–6.

Tkachova OV, Silaev AO, Sheptak TI. Analysis of antiviral drugs consumption on the pharmaceutical market of ukraine which are used for pharmacotherapy in arvi patients. Ukraïns’kij bìofarmacevtičnij žurnal. 2018;0(1(54):35–40. DOI: https://doi.org/10.24959/ubphj.18.161

Downloads

Published

2020-06-15

How to Cite

Kotvitska, A. A., & Prokopenko, O. S. (2020). THE ANALYSIS OF CONSUMPTION MARKERS OF PARKINSON’S DISEASE TREATMENT MEDICINES IN UKRAINE. Pharmaceutical Review Farmacevtičnij časopis, (2), 51–59. https://doi.org/10.11603/2312-0967.2020.2.11191

Issue

No. 2 (2020)

Section

Pharmaceutical management, marketing and logistics

License

The authors who publish their materials in this journal agree with the following terms:

  • Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal Результат пошуку зображень за запитом "CC-BY logo".
  • Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.

Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).